CompletedNCT01323569
Abuse Potential of Sativex
Medication studyAges 19–45CanadaAddiction
Understand this study
Who was this study for?
Listed age limits: 19 years to 45 years.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateFebruary 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 58
- Sponsor
- Jazz Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- Canada
- Age range
- From 19 Years to 45 Years
- Official registry ID
- NCT01323569
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Abuse Potential of Sativex in Subjects With a History of Recreational Marijuana Use
Recruitment & locations
CompletedToronto
Questions about this study
Who is behind this study?
The study sponsor is Jazz Pharmaceuticals.
Did this study involve medication?
Yes. The study involved medication, including Sativex, Placebo and Marinol.
Who was this study for?
Listed age limits: 19 years to 45 years.
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit me